Concepedia

Author

Yongyu Liu

Liaoning Cancer Hospital & InstituteORCID

Also Known As

De-Gui Liu, De-gui LIU, Degui Liu, Hui Wang, Jianhua Fu, Lin Peng, Liu, Yongyu, Qianwen Liu, Shun-shou Liu, Shun‐Shou Liu

113

Publications

3.5K

Citations

31

H-Index

44

Concepts

All Affiliations

Liaoning Cancer Hospital & InstituteFudan UniversitySun Yat-sen UniversityZhejiang Cancer HospitalPeking University Cancer Hospital
YL

About

Yongyu Liu is an author at Liaoning Cancer Hospital & Institute specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

9

713

2

Public Health

3

3

276

3

Epidemiology

3

3

276

4

Immunology

3

4

139

5

Health Sciences

1

1

10

Yongyu Liu

×

31

Publications

1.6K

Citations

22

H-Index

YearCitations

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial

Dongsheng Yue, Shidong Xu, Qun Wang,

The Lancet Respiratory Medicine

2018

288

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Wen‐Zhao Zhong, Qun Wang, Weimin Mao,

Journal of Clinical Oncology

2020

261

Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity

Yu Chen, Yaguo Wang, Joy Fleming,

2020

234

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Si‐Yang Liu, Hua Bao, Qun Wang,

Nature Communications

2021

70

Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer

Dongsheng Yue, Shidong Xu, Qun Wang,

Journal of Clinical Oncology

2022

59

Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis

Zhitao Gu, Jianhua Fu, Yi Shen,

Journal of Thoracic Disease

2016

55

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand,

Journal of the American Heart Association

2019

54

<p>Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma</p>

Na Li, Lan Zhao, Chunyan Guo,

Cancer Management and Research

2019

46

Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice

Liang Zhang, Yi Ren, Chengliang Yang,

Inflammation

2014

42

Perioperative outcomes and long-term survival in clinically early-stage thymic malignancies: video-assisted thoracoscopic thymectomy versus open approaches

Hao Wang, Zhitao Gu, Jianyong Ding,

Journal of Thoracic Disease

2016

41

Page 1